Circulating tumor cells in metastatic breast cancer - Toward individualized treatment?

被引：40
作者：
Braun, S [1 ]
Marth, C
机构：
[1] Innsbruck Med Univ, Dept Obstet & Gynecol, Innsbruck, Austria
[2] Innsbruck Med Univ, Breast Hlth Ctr, Innsbruck, Austria
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2004年 / 351卷 / 08期
关键词：
D O I：
10.1056/NEJMe048163
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：824 / 826
页数：3
相关论文
共 10 条
[1]  
[Anonymous], 2000, NEW ENGL J MED, V343, P308
[2]   Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer. [J].
Braun, S ;
Pantel, K ;
Muller, P ;
Janni, W ;
Hepp, F ;
Kentenich, CRM ;
Gastroph, S ;
Wischnik, A ;
Dimpfl, T ;
Kindermann, G ;
Riethmuller, G ;
Schlimok, G .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (08) :525-533
[3]   Evaluation of bone marrow in breast cancer patients: prediction of clinical outcome and response to therapy [J].
Braun, S ;
Vogl, FD ;
Janni, W ;
Marth, C ;
Schlimok, G ;
Pantel, K .
BREAST, 2003, 12 (06) :397-404
[4]   Circulating tumor cells, disease progression, and survival in metastatic breast cancer [J].
Cristofanilli, M ;
Budd, GT ;
Ellis, MJ ;
Stopeck, A ;
Matera, J ;
Miller, MC ;
Reuben, JM ;
Doyle, GV ;
Allard, WJ ;
Terstappen, LWMM ;
Hayes, DF .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (08) :781-791
[5]   Comparative genomic hybridization, loss of heterozygosity, and DNA sequence analysis of single cells [J].
Klein, CA ;
Schmidt-Kittler, O ;
Schardt, JA ;
Pantel, K ;
Speicher, MR ;
Riethmüller, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (08) :4494-4499
[6]   Development of donor-derived prostate cancer in a recipient following orthotopic heart transplantation [J].
Loh, E ;
Couch, FJ ;
Hendricksen, C ;
Farid, L ;
Kelly, PF ;
Acker, MA ;
Tomaszewski, JE ;
Malkowicz, SB ;
Weber, BL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (02) :133-137
[7]   A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen [J].
Ma, XJ ;
Wang, ZC ;
Ryan, PD ;
Isakoff, SJ ;
Barmettler, A ;
Fuller, A ;
Muir, B ;
Mohapatra, G ;
Salunga, R ;
Tuggle, JT ;
Tran, Y ;
Tran, D ;
Tassin, A ;
Amon, P ;
Wang, W ;
Wang, W ;
Enright, E ;
Stecker, K ;
Estepa-Sabal, E ;
Smith, B ;
Younger, J ;
Balis, U ;
Michaelson, J ;
Bhan, A ;
Habin, K ;
Baer, TM ;
Brugge, J ;
Haber, DA ;
Erlander, MG ;
Sgroi, DC .
CANCER CELL, 2004, 5 (06) :607-616
[8]  
Müller HM, 2003, CANCER RES, V63, P7641
[9]  
Paget S., LANCET, V1, P571
[10]  
Stieber Petra, 2003, Clin Lab, V49, P15
1